Transform for OpenClinica will allow us to continue our ongoing mission of delivering more choice for study build, as well as reducing the need for training in multiple systems.
Burlington, MA (PRWEB) October 25, 2013
Formedix, leading provider of clinical trial automation software and consultancy services is excited to announce a new partnership with OpenClinica, LLC, producers of the world’s most widely used open source electronic data capture software. The two companies are collaborating to offer an integration between Formedix Origin universal clinical trial design tools and OpenClinica’s uniquely flexible open source system for Electronic Data Capture (EDC) and Clinical Data Management.
The product, named Formedix Transform for OpenClinica, reaches the market this week and joins the company’s ever-expanding range of integrations with the leading EDC systems on the market. Transform for OpenClinica, a new integration with Formedix Universal Design Tool, Origin, merges study specification and EDC build into one process to significantly reduce OpenClinica study build times--in some cases by more than 55%. Other capabilities include study build automation and drag-and-drop reuse, enhanced by leveraging portable, vendor neutral CDISC designs.
CROs and sponsors now have even greater choice when selecting an EDC system with the introduction of Transform for OpenClinica and its diverse capabilities. There is no longer a need for training and support in multiple systems because, with Formedix, training only needs to be given for one study design tool.
Earlier this year, Mark Wheeldon, CEO of Formedix, was invited to present at OC13, the 2013 OpenClinica Global Conference, discussing the use of CDISC standards to drive efficiencies in study set-up and build with OpenClinica. He also spoke in detail about how Formedix is working with partners, such as OpenClinica, to develop cutting-edge solutions to help achieve further reductions in study build times.
Mark said, “Formedix Transform enables users to design in one environment and interface with multiple systems, broadening the scope of CROs and EDC vendors. By providing a vendor neutral solution, our customers can choose one, work with all. Transform for OpenClinica will allow us to continue our ongoing mission of delivering more choice for study build, as well as reducing the need for training in multiple systems.”
He added, “We are delighted to add to our wide portfolio of Transform tools and partner with OpenClinica, to offer even more choice to our customers. We are the only independent provider of multi-vendor solutions for clinical trial automation and we continue to build our network of technology partnerships to enhance this proposition.”
Formedix clinical trial automation software and services enable you to remove manual, expensive, inefficient and labor intensive tasks from study set-up, EDC build, validation and submission publication processes.
In fact, across every facet of your end-to-end clinical trial, the time and cost savings they deliver speak for themselves and continue to do so time and time again.
Formedix saves 68% in set-up time and 55% in EDC build time. With 70% reuse of your content, resources are cut by 23%. It’s all in the numbers.
Your Clinical Trials Automated. Everywhere.
OpenClinica, LLC is the global leader in open source EDC | CDMS software with thousands of implementations at contract research organizations, biopharmaceutical companies, academic, and government organizations. The powerful tools and superior quality system increase the speed of data collection and ensure data integrity in clinical trials. OpenClinica supports ICH, GCP, 21 CFR Part 11, HIPAA, and other regulatory guidelines, and is designed as a standards-based, extensible, and modular platform.
For more information visit https://www.openclinica.com.